| 17beta-estradiol | decreases expression | ISO | RGD:1353008 | 6480464 | Estradiol results in decreased expression of HSD17B2 mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | decreases expression | ISO | RGD:1353008 | 6480464 | Estradiol results in decreased expression of HSD17B2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1353008 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of HSD17B2 mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Estradiol | CTD | PMID:16054388 |
| 17beta-estradiol | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Estradiol | CTD | PMID:16054388 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of HSD17B2 mRNA | CTD | PMID:20005886 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1353008 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:621803 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:621803 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD17B2 mRNA | CTD | PMID:20959002 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1353008 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:621803 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD17B2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:621803 | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSD17B2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1353008 | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSD17B2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:20005886 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:621803 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:19692669 PMID:16054898 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:621803 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:16054898 PMID:19692669 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:621803 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:16054898 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:20005886 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of HSD17B2 mRNA | CTD | PMID:16214954 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSD17B2 mRNA | CTD | PMID:20702594 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:621803 | 6480464 | 2,4-dinitrotoluene affects the expression of HSD17B2 mRNA | CTD | PMID:21346803 |
| 2-methoxy-17beta-estradiol | multiple interactions | ISO | RGD:1353008 | 6480464 | [HSD17B2 protein results in increased metabolism of and results in decreased activity of 2-methoxyestradiol] which results in increased chemical synthesis of 2-methoxyestrone | CTD | PMID:16397246 |
| 2-methoxy-17beta-estradiol | decreases response to substance | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in decreased susceptibility to 2-methoxyestradiol | CTD | PMID:16397246 |
| 2-methoxyestrone | multiple interactions | ISO | RGD:1353008 | 6480464 | [HSD17B2 protein results in increased metabolism of and results in decreased activity of 2-methoxyestradiol] which results in increased chemical synthesis of 2-methoxyestrone | CTD | PMID:16397246 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:621803 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of HSD17B2 mRNA | CTD | PMID:19692669 |
| 5-fluorouracil | affects expression | ISO | RGD:1353008 | 6480464 | Fluorouracil affects the expression of HSD17B2 mRNA | CTD | PMID:16584549 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:1353008 | 6480464 | bisphenol A inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA] | CTD | PMID:21273127 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1353008 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA | CTD | PMID:21273127 |
| aflatoxin B1 | affects expression | ISO | RGD:1353008 | 6480464 | Aflatoxin B1 affects the expression of HSD17B2 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1353008 | 6480464 | Tretinoin results in increased expression of HSD17B2 mRNA | CTD | PMID:16249480 |
| ammonium chloride | affects expression | ISO | RGD:621803 | 6480464 | Ammonium Chloride affects the expression of HSD17B2 mRNA | CTD | PMID:16483693 |
| androst-4-ene-3,17-dione | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Androstenedione | CTD | PMID:16054388 |
| androst-5-ene-3beta,17beta-diol | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Androstenediol | CTD | PMID:16054388 |
| androst-5-ene-3beta,17beta-diol | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Androstenediol | CTD | PMID:16054388 |
| antimony(0) | decreases expression | ISO | RGD:1353008 | 6480464 | Antimony results in decreased expression of HSD17B2 mRNA | CTD | PMID:17547211 |
| atrazine | decreases expression | ISO | RGD:621803 | 6480464 | Atrazine results in decreased expression of HSD17B2 mRNA | CTD | PMID:22285353 |
| benzo[a]pyrene | increases expression | ISO | RGD:1353008 | 6480464 | Benzo(a)pyrene results in increased expression of HSD17B2 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of HSD17B2 mRNA | CTD | PMID:21715664 |
| bisphenol A | multiple interactions | ISO | RGD:1353008 | 6480464 | bisphenol A inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA] | CTD | PMID:21273127 |
| bisphenol A | decreases expression | ISO | RGD:621803 | 6480464 | bisphenol A results in decreased expression of HSD17B2 mRNA | CTD | PMID:22285353 |
| calcitriol | increases expression | ISO | RGD:1353008 | 6480464 | Calcitriol results in increased expression of HSD17B2 mRNA | CTD | PMID:21592394 PMID:16002434 |
| calcitriol | increases expression | ISO | RGD:1353008 | 6480464 | Calcitriol results in increased expression of HSD17B2 mRNA | CTD | PMID:16002434 PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:1353008 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of HSD17B2 mRNA | CTD | PMID:21592394 |
| cefaloridine | decreases expression | ISO | RGD:621803 | 6480464 | Cephaloridine results in decreased expression of HSD17B2 mRNA | CTD | PMID:18500788 |
| cisplatin | decreases expression | ISO | RGD:621803 | 6480464 | Cisplatin results in decreased expression of HSD17B2 mRNA | CTD | PMID:22023808 |
| copper atom | multiple interactions | ISO | RGD:1353008 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of HSD17B2 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1353008 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of HSD17B2 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1353008 | 6480464 | Copper Sulfate results in decreased expression of HSD17B2 mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | ISO | RGD:1353008 | 6480464 | Cyclosporine results in decreased expression of HSD17B2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1353008 | 6480464 | Cyclosporine results in decreased expression of HSD17B2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| dehydroepiandrosterone | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Dehydroepiandrosterone | CTD | PMID:16054388 |
| dehydroepiandrosterone | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Dehydroepiandrosterone | CTD | PMID:16054388 |
| dexamethasone | decreases expression | ISO | RGD:621803 | 6480464 | Dexamethasone results in decreased expression of HSD17B2 mRNA | CTD | PMID:20607812 |
| diarsenic trioxide | decreases expression | ISO | RGD:1353008 | 6480464 | arsenic trioxide results in decreased expression of HSD17B2 mRNA | CTD | PMID:17547211 |
| diethyl maleate | decreases expression | ISO | RGD:621803 | 6480464 | diethyl maleate results in decreased expression of HSD17B2 mRNA | CTD | PMID:21161181 |
| dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | decreases expression | ISO | RGD:1353008 | 6480464 | Antimony Potassium Tartrate results in decreased expression of HSD17B2 mRNA | CTD | PMID:17547211 |
| diuron | increases expression | ISO | RGD:621803 | 6480464 | Diuron results in increased expression of HSD17B2 mRNA | CTD | PMID:21551480 |
| estrone | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Estrone | CTD | PMID:16054388 |
| estrone | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Estrone | CTD | PMID:16054388 |
| furan | increases expression | ISO | RGD:621803 | 6480464 | furan results in increased expression of HSD17B2 mRNA | CTD | PMID:15120968 |
| furan | increases methylation | ISO | RGD:621803 | 6480464 | furan results in increased methylation of HSD17B2 gene | CTD | PMID:22079235 |
| hexachlorobenzene | decreases expression | ISO | RGD:621803 | 6480464 | Hexachlorobenzene results in decreased expression of HSD17B2 mRNA | CTD | PMID:15159207 |
| hydrogen peroxide | affects expression | ISO | RGD:1353008 | 6480464 | Hydrogen Peroxide affects the expression of HSD17B2 mRNA | CTD | PMID:20044591 |
| methoxychlor | decreases expression | ISO | RGD:621803 | 6480464 | Methoxychlor results in decreased expression of HSD17B2 mRNA | CTD | PMID:22285353 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:621803 | 6480464 | Diethylnitrosamine results in decreased expression of HSD17B2 mRNA | CTD | PMID:19638242 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621803 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HSD17B2 mRNA | CTD | PMID:18164116 |
| N-nitrosodimethylamine | decreases expression | ISO | RGD:1353008 | 6480464 | Dimethylnitrosamine results in decreased expression of HSD17B2 mRNA | CTD | PMID:17547211 |
| N-nitrosodimethylamine | decreases expression | ISO | RGD:621803 | 6480464 | Dimethylnitrosamine results in decreased expression of HSD17B2 mRNA | CTD | PMID:17072980 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of HSD17B2 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1353008 | 6480464 | Acetaminophen results in increased expression of HSD17B2 mRNA | CTD | PMID:22230336 |
| paracetamol | decreases expression | ISO | RGD:1353008 | 6480464 | Acetaminophen results in decreased expression of HSD17B2 mRNA | CTD | PMID:21420995 |
| paracetamol | decreases expression | ISO | RGD:621803 | 6480464 | Acetaminophen results in decreased expression of HSD17B2 mRNA | CTD | PMID:15120968 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of HSD17B2 mRNA | CTD | PMID:20118188 |
| perfluorooctanoic acid | increases expression | ISO | RGD:621803 | 6480464 | perfluorooctanoic acid results in increased expression of HSD17B2 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of HSD17B2 mRNA] | CTD | PMID:20118188 |
| phenobarbital | decreases expression | ISO | RGD:621803 | 6480464 | Phenobarbital results in decreased expression of HSD17B2 mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of HSD17B2 mRNA | CTD | PMID:23091169 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of HSD17B2 mRNA | CTD | PMID:18445702 |
| pirinixic acid | increases expression | ISO | RGD:621803 | 6480464 | pirinixic acid results in increased expression of HSD17B2 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:621803 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of HSD17B2 mRNA | CTD | PMID:19162173 |
| progesterone | multiple interactions | ISO | RGD:1353008 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of HSD17B2 mRNA | CTD | PMID:17404688 |
| quercetin | decreases expression | ISO | RGD:1353008 | 6480464 | Quercetin results in decreased expression of HSD17B2 mRNA | CTD | PMID:21632981 |
| resveratrol | increases expression | ISO | RGD:621803 | 6480464 | resveratrol results in increased expression of HSD17B2 mRNA | CTD | PMID:19228061 |
| sevoflurane | affects expression | ISO | RGD:621803 | 6480464 | sevoflurane affects the expression of HSD17B2 mRNA | CTD | PMID:15967596 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of HSD17B2 mRNA | CTD | PMID:20937368 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of HSD17B2 mRNA | CTD | PMID:15003993 |
| testosterone | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Testosterone | CTD | PMID:16054388 |
| testosterone | increases expression | ISO | RGD:1353008 | 6480464 | Testosterone results in increased expression of HSD17B2 mRNA | CTD | PMID:21592394 |
| testosterone | multiple interactions | ISO | RGD:1353008 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of HSD17B2 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | affects expression | ISO | RGD:621803 | 6480464 | Carbon Tetrachloride affects the expression of HSD17B2 mRNA | CTD | PMID:16239168 |
| tetracycline | increases expression | EXP | | 6480464 | Tetracycline results in increased expression of HSD17B2 mRNA | CTD | PMID:16917069 |
| trans-resveratrol | increases expression | ISO | RGD:621803 | 6480464 | resveratrol results in increased expression of HSD17B2 mRNA | CTD | PMID:19228061 |
| troglitazone | decreases expression | ISO | RGD:621803 | 6480464 | troglitazone results in decreased expression of HSD17B2 mRNA | CTD | PMID:21515302 |
| zearalenone | increases expression | ISO | RGD:621803 | 6480464 | Zearalenone results in increased expression of HSD17B2 mRNA | CTD | PMID:20607812 |
| zinc atom | decreases expression | ISO | RGD:621803 | 6480464 | Zinc deficiency results in decreased expression of HSD17B2 mRNA | CTD | PMID:15671213 |
| zinc(0) | decreases expression | ISO | RGD:621803 | 6480464 | Zinc deficiency results in decreased expression of HSD17B2 mRNA | CTD | PMID:15671213 |